Christiana Bardon, M.D., M.B.A.

About

Dr. Christiana (Chris) Bardon is Managing Partner of MPM BioImpact and leads the firm’s public market investing as portfolio manager for BioImpact Equities and the Oncology Impact Funds. Previously, Chris was a health care analyst at Fidelity Investments covering biotechnology, life-science tools and diagnostics, and she started her career as an analyst at MPM BioImpact. She currently serves as an Executive Fellow at the Harvard Business School, on the Harvard Medical School Board of Fellows, and is a Trustee of the American Association for Cancer Research Foundation.

Source (opens in a new tab)